Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Dynamic variation in allele-specific gene expression of Paraoxonase-1 in murine and human tissues.

Parker-Katiraee L, Bousiaki E, Monk D, Moore GE, Nakabayashi K, Scherer SW.

Hum Mol Genet. 2008 Nov 1;17(21):3263-70. doi: 10.1093/hmg/ddn222. Epub 2008 Aug 4.

2.

Allelic variation in gene expression is common in the human genome.

Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP.

Genome Res. 2003 Aug;13(8):1855-62.

3.

Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene.

Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H.

Ann Hum Genet. 2004 Mar;68(Pt 2):110-9.

PMID:
15008790
5.

Extensive tissue-specific variation of allelic methylation in the Igf2 gene during mouse fetal development: relation to expression and imprinting.

Weber M, Milligan L, Delalbre A, Antoine E, Brunel C, Cathala G, Forné T.

Mech Dev. 2001 Mar;101(1-2):133-41.

6.

Identification of transcriptome SNPs for assessing allele-specific gene expression in a super-hybrid rice Xieyou9308.

Zhai R, Feng Y, Zhan X, Shen X, Wu W, Yu P, Zhang Y, Chen D, Wang H, Lin Z, Cao L, Cheng S.

PLoS One. 2013 Apr 17;8(4):e60668. doi: 10.1371/journal.pone.0060668. Print 2013.

7.

Expression of human paraoxonase (PON1) during development.

Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, Furlong CE.

Pharmacogenetics. 2003 Jun;13(6):357-64.

PMID:
12777966
8.

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.

Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD.

Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26.

PMID:
21803130
9.

Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.

Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B.

J Toxicol Environ Health B Crit Rev. 2009;12(5-6):473-507. doi: 10.1080/10937400903158409. Review.

PMID:
20183530
10.

A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Neurotoxicology. 2007 May;28(3):532-40. Epub 2006 Nov 26.

PMID:
17204329
12.
13.

The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.

Rausa F, Samadani U, Ye H, Lim L, Fletcher CF, Jenkins NA, Copeland NG, Costa RH.

Dev Biol. 1997 Dec 15;192(2):228-46.

14.
15.

DNA methylation contributes to tissue- and allele-specific expression of the T-cell differentiation marker RT6.

Rothenburg S, Koch-Nolte F, Thiele HG, Haag F.

Immunogenetics. 2001;52(3-4):231-41.

PMID:
11220625
16.

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT.

J Natl Cancer Inst. 2003 Jun 4;95(11):812-8.

PMID:
12783936
17.

Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.

Deakin S, Guernier S, James RW.

Pharmacogenet Genomics. 2007 Jun;17(6):451-7.

PMID:
17502837
18.

Genetic variations of the paraoxonase gene in patients with coronary artery disease.

Hong SH, Song J, Min WK, Kim JQ.

Clin Biochem. 2001 Sep;34(6):475-81.

PMID:
11676977
19.

Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment.

Mertens J, Ramadori G, Mihm S.

Hum Mol Genet. 2010 Dec 1;19(23):4587-94. doi: 10.1093/hmg/ddq386. Epub 2010 Sep 15.

PMID:
20846942

Supplemental Content

Support Center